A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Completed
Meda Pharmaceuticals
Phase 3
2007-12-01
The purpose of this study is to determine if two allergy medications (azelastine and
fluticasone) are more effective than placebo or either medication alone (azelastine or
fluticasone)
Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
Completed
Meda Pharmaceuticals
Phase 3
2006-07-01
The purpose of this study is to determine if Astepro Nasal Spray (0.1% azelastine
hydrochloride) is as safe as Astelin Nasal Spray (0.1% azelastine hydrochloride)
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Completed
Meda Pharmaceuticals
Phase 3
2009-04-01
The purpose of this study is to determine if the combination of two allergy medications
(formulated azelastine/fluticasone product)is more effective than placebo or either component
medication alone (azelastine or fluticasone).
Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis
Completed
Ligand Pharmaceuticals
Phase 2
2008-02-01
The primary objective of this study was to compare Placebo to Captisol-Enabled Budesonide +
Azelastine in a single spray and two separate sprays (Budesonide + Azelastine) in patients
with Seasonal Allergic Rhinitis exposed to controlled ragweed pollen.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
